Bolar Fined 10 Million for Mislabeling
Selected Abstract
Bolar Fined $10 Million for Mislabeling Drugs;Penalty Against Manufacturer of Generics Is Largest Assessed in FDA Criminal Case
Bolar Pharmaceutical Co., once the nation's leading generic drug manufacturer, was fined $10 million in federal court today after pleading guilty to mislabeling and adulterating eight drugs used by millions of consumers and then masterminding a massive coverup of its activities. The fine, the ... March 23, 1991; The Washington Post
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bolar Fined $10 Million for Mislabeling Drugs;Penalty Against Manufacturer of Generics Is Largest Assessed in FDA Criminal Case
|
